Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine effects on cognition, attention, and reward learning in healthy young men
NL-OMON43560Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of atomoxetine, sponsored by Maastricht University. Primary endpoint: Performance on neuropsychological tests and associated brain activity. Started Nov 2015; status: active, not recruiting.
02
Drugs
atomoxetine
Beyond the preview
Go deeper on NL-OMON43560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43560.